ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 322 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,734,000 | -35.9% | 61,700 | -58.9% | 0.02% | -40.6% |
| Q3 2021 | $8,939,000 | +443.7% | 150,100 | +522.8% | 0.03% | +433.3% |
| Q2 2021 | $1,644,000 | -59.9% | 24,100 | -59.2% | 0.01% | -68.4% |
| Q1 2021 | $4,098,000 | +79.6% | 59,062 | +98.9% | 0.02% | +90.0% |
| Q4 2020 | $2,282,000 | +377.4% | 29,700 | +364.1% | 0.01% | +400.0% |
| Q3 2020 | $478,000 | +124.4% | 6,400 | +36.2% | 0.00% | 0.0% |
| Q4 2019 | $213,000 | -36.6% | 4,700 | -35.9% | 0.00% | -33.3% |
| Q3 2019 | $336,000 | +52.7% | 7,333 | +96.1% | 0.00% | +50.0% |
| Q2 2019 | $220,000 | -46.6% | 3,740 | -59.3% | 0.00% | -33.3% |
| Q1 2019 | $412,000 | -20.8% | 9,200 | -31.0% | 0.00% | 0.0% |
| Q4 2018 | $520,000 | – | 13,336 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |